Trial intelligence / Profile preview

Fibrinogen and bleeding after cardiac surgery

2007-007157-31Phase 2Completed

Sponsor
Sahlgrenska University Hospital
Start
Feb 2008
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 2 trial of Fibrinogen human in coronary arteriosclerosis and perioperative bleeding, sponsored by Sahlgrenska University Hospital. Primary endpoint: Number of transfusions with blood products during hospital stay. Started Feb 2008; status: completed.

02

Drugs

Fibrinogen human
03

Conditions

coronary arteriosclerosisperioperative bleeding

Beyond the preview

Go deeper on 2007-007157-31.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2007-007157-31.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call